Skip to content

Japanese lung cancer registry study: Japanese joint committee of lung cancer registry database of patients who underwent resections in 2021

Japanese lung cancer registry study: Japanese joint committee of lung cancer registry database of patients who underwent resections in 2021 - Japanese lung cancer registry study: Japanese joint committee of lung cancer registry database of patients who underwent resections in 2021

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042437
Enrollment
15000
Registered
2020-11-13
Start date
2021-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary lung cancer

Interventions

None listed

Sponsors

Japanese Joint Committee of Lung Cancer Registry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Patient enrolled from institutions participating in this study that wish to participate in university hospitals and regional core facilities nationwide 2 Patients aged 20 years or older 3 Patients undergoing surgical treatment from January 1, 2021, to December 31, 2021 4 Except for diagnostic procedures 5 Include patients who have resulted in exploratory thoracotomy

Exclusion criteria

Exclusion criteria: 1 Patient who declined to participate in the study 2 patient undergoing diagnostic surgery

Design outcomes

Primary

MeasureTime frame
A nationwide prospective registry study utilizing NCD data on the prognosis and clinicopathological profiles of resected lung cancer in 2021

Secondary

MeasureTime frame
To identify predictive factors of surgical outcome for lung cancer treated in 2021

Countries

Japan

Contacts

Public ContactHidemi Suzuki

Chiba University Graduate School of Medicine General Thoracic Surgery

src-jjclcr@haigan-touroku.org0432227171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026